Chorioretinopathy Post COVID-19: A Systematic Review and Prevalence Assessment, Unveiling Insights into an Emerging Ocular Entity

REFERENCES

• Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157–60. doi:10.23750/abm.v91i1.9397.
   PubMedGoogle Scholar
• Munblit D, Nicholson T, Akrami A, Apfelbacher C, Chen J, De Groote W, Diaz JV, Gorst SL, Harman N, Kokorina A, Olliaro P. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir Med. 2022;10(7):715–724. doi:10.1016/S2213-2600(22)00169-2.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Wang K, Zhu Y, Lyu D, Yu Y, Li S, Yao K. Ocular manifestations in COVID-19 patients: a systematic review and meta-analysis. Travel Med Infect Dis. 2021;44:102191. doi:10.1016/j.tmaid.2021.102191.
   PubMed Web of Science ®Google Scholar
• Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol. 2013;41(2):201–14. doi:10.1111/j.1442-9071.2012.02848.x.
   PubMed Web of Science ®Google Scholar
• Sesar AP, Sesar A, Bucan K, Sesar I, Cvitkovic K, Cavar I Personality traits, stress, and emotional intelligence associated with central serous chorioretinopathy. Med Sci Monit. 2021;27:e928677. doi:10.12659/MSM.928677.
   PubMed Web of Science ®Google Scholar
• To KF, Lo AW. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol. 2004;203(3):740–3. doi:10.1002/path.1597.
   PubMed Web of Science ®Google Scholar
• Erturk SB, Tukenmez TE, Ilgin C, Korten V, Odabasi Z. Prognostic values of baseline cortisol levels and neutrophil to lymphocyte ratio in COVID-19. J Med Biochem. 2023;42(3):437–443. doi:10.5937/jomb0-38533.
   PubMed Web of Science ®Google Scholar
• Goyal M, Murthy SI, Annum S. Retinal manifestations in patients following COVID-19 infection: a consecutive case series. Indian, J Ophthalmol. 2021;69(5):1275–82. doi:10.4103/ijo.IJO_403_21.
   PubMed Web of Science ®Google Scholar
• Sanjay S, Rao VK, Mutalik D, Mahendradas P, Kawali A, Shetty R. Post corona virus disease-19 (COVID-19): hyper inflammatory syndrome-associated bilateral anterior uveitis and multifocal serous retinopathy secondary to steroids. Indian J Rheumatol. 2021;16(4):451–455. doi:10.4103/injr.injr_330_20.
   Web of Science ®Google Scholar
• Mahjoub A, Dlensi A, Romdhane A, Ben Abdesslem N, Mahjoub A, Bachraoui C, Mahjoub H, Ghorbel M, Knani L, Krifa F. Choriorétinopathie séreuse centrale bilatérale post-COVID-19. J Fr Ophtalmol. 2021;44(10):1484–1490. doi:10.1016/j.jfo.2021.10.001.
   PubMedGoogle Scholar
• Sanjay S, Gowda PB, Rao B, Mutalik D, Mahendradas P, Kawali A, Shetty, R. “Old wine in a new bottle” - post COVID-19 infection, central serous chorioretinopathy and the steroids. J Ophthalmic Inflamm Infect. 2021;11(1):14. doi:10.1186/s12348-021-00244-4.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(jul21 1):b2535. doi:10.1136/bmj.b2535.
   PubMed Web of Science ®Google Scholar
• Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18:2127–2133. doi:10.11124/JBISRIR-D-19-00099.
   PubMedGoogle Scholar
• Sharifi A, Daneshtalab A, Zand A Bilateral central serous chorioretinopathy after treatment of COVID-19 infection. Cureus. 2022;14:e23446. doi:10.7759/cureus.23446.
   PubMed Web of Science ®Google Scholar
• Nicolai M, Carpenè MJ, Lassandro NV, Pelliccioni P, Pirani V, Franceschi A, Mariotti C. Punctate inner choroidopathy reactivation following COVID-19: a case report. Eur J Ophthalmol. 2022;32(4):Np6–np10. doi:10.1177/11206721211028750.
   PubMed Web of Science ®Google Scholar
• Mohd-Alif WM, Nur-Athirah A, Hanapi MS, Tuan Jaffar TN, Shatriah I Bilateral and multiple central serous chorioretinopathy following COVID-19 infection: a case report and literature review. Cureus. 2022;14:e23246. doi:10.7759/cureus.23246.
   PubMed Web of Science ®Google Scholar
• Fuganti RM, Casella AM, Roisman L, Zett C, Maia M, Farah ME, Lima LH. Case series bacillary layer detachment associated with acute central serous chorioretinopathy in patients with COVID-19. Am J Ophthalmol Case Rep. 2022;28:101690. doi:10.1016/j.ajoc.2022.101690.
   PubMedGoogle Scholar
• Miyata M, Ooto S, Muraoka Y. Punctate inner choroidopathy immediately after COVID-19 infection: a case report. BMC Ophthalmol. 2022;22(1):297. doi:10.1186/s12886-022-02514-8.
   PubMed Web of Science ®Google Scholar
• Amulya G, Thanuja GP, editors. Central Serous Retinopathy in a Post COVID-19 Asymptomatic Healthcare Worker at a Tertiary Care Hospital: A Unique Case Report. UK: Ophthalmology Research: An International Journal; 2021.
   Google Scholar
• Aidar MN, Gomes TM, MZH DA, de Andrade EP, Serracarbassa PD Low visual acuity due to acute macular neuroretinopathy associated with COVID-19: a case report. Am J Case Rep. 2021;22:e931169. doi:10.12659/AJCR.931169.
   PubMed Web of Science ®Google Scholar
• Bøhler AD, Strøm ME, Sandvig KU, Moe MC, Jørstad ØK. Acute macular neuroretinopathy following COVID-19 vaccination. Eye (Lond). 2022;36(3):644–645. doi:10.1038/s41433-021-01610-1.
   PubMed Web of Science ®Google Scholar
• Jain A, Shilpa IN, Biswas J. Multiple evanescent white dot syndrome following SARS-CoV-2 infection - a case report. Indian, J Ophthalmol. 2022;70(4):1418–20. doi:10.4103/ijo.IJO_3093_21.
   PubMed Web of Science ®Google Scholar
• Inagawa S, Onda M, Miyase T, Murase S, Murase H, Mochizuki K, Sakaguchi H. Multiple evanescent white dot syndrome following vaccination for COVID-19: a case report. Medicine. 2022;101(2):e28582. doi:10.1097/MD.0000000000028582.
   PubMed Web of Science ®Google Scholar
• Providência J, Fonseca C, Henriques F, Proença R. Serpiginous choroiditis presenting after SARS-CoV-2 infection: a new immunological trigger? Eur J Ophthalmol. 2022;32(1): Np 97–np101. doi:10.1177/1120672120977817.
   Web of Science ®Google Scholar
• Goyal M, Murthy SI, Annum S. Bilateral multifocal choroiditis following COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(4):753–7. doi:10.1080/09273948.2021.1957123.
   PubMed Web of Science ®Google Scholar
• Kakarla PD, Venugopal RYC, Manechala UB, Rijey J, Anthwal D. Bilateral multifocal choroiditis with disc edema in a 15-year-old girl following COVID-19 vaccination. Indian, J Ophthalmol. 2022;70(9):3420–2. doi:10.4103/ijo.IJO_861_22.
   PubMed Web of Science ®Google Scholar
• Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384:693–704.
   PubMed Web of Science ®Google Scholar
• Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013;58(2):103–26. doi:10.1016/j.survophthal.2012.07.004.
   PubMed Web of Science ®Google Scholar
• Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82–118. doi:10.1016/j.preteyeres.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Daruich A, Matet A, Marchionno L, De Azevedo JD, Ambresin A, Mantel I, Behar-Cohen F. Acute central serous chorioretinopathy: factors influencing episode duration. Retina. 2017;37(10):1905–15. doi:10.1097/IAE.0000000000001443.
   PubMed Web of Science ®Google Scholar
• Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients. Br J Ophthalmol. 2019;103(6):725–9. doi:10.1136/bjophthalmol-2018-312431.
   PubMed Web of Science ®Google Scholar
• Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology. 2008;115(1):169–173. doi:10.1016/j.ophtha.2007.02.032.
   PubMed Web of Science ®Google Scholar
• Mansour AM, Koaik M, Lima LH, Casella AMB, Uwaydat SH, Shahin M, Tamim H, Sanchez-Ruiz MJ, Mansour HA, Dodwell D. Physiologic and psychologic risk factors in central serous chorioretinopathy. Ophthalmol Retina. 2017;1(6):497–507. doi:10.1016/j.oret.2017.02.009.
   PubMedGoogle Scholar
• Singh SR, Iovino C, Zur D, Masarwa D, Iglicki M, Gujar R, Lupidi M, Maltsev DS, Bousquet E, Bencheqroun M, Amoroso F. Central serous chorioretinopathy imaging biomarkers. Br J Ophthalmol. 2022;106(4):553–8. doi:10.1136/bjophthalmol-2020-317422.
   PubMed Web of Science ®Google Scholar
• Roisman L, Lavinsky D, Magalhaes F, et al. Fundus Autofluorescence and Spectral Domain OCT in Central Serous Chorioretinopathy. J Ophthalmol. 2011;2011:1–4. doi:10.1155/2011/706849.
   Web of Science ®Google Scholar
• Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. discussion 9-80. 1996;103(12):2070–2079. doi:10.1016/S0161-6420(96)30386-2.
   PubMed Web of Science ®Google Scholar
• Liu B, Deng T, Zhang J. Risk factors for central serous chorioretinopathy: a systematic review and meta-analysis. Retina. 2016;36(1):9–19. doi:10.1097/IAE.0000000000000837.
   PubMed Web of Science ®Google Scholar
• Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun. 2020;89:531–42. doi:10.1016/j.bbi.2020.05.048.
   PubMed Web of Science ®Google Scholar
• Chhablani J, Anantharaman G, Behar-Cohen F, Boon C, Manayath G, Singh R. Management of central serous chorioretinopathy: Expert panel discussion. Indian, J Ophthalmol. 2018;66(12):1700–3. doi:10.4103/ijo.IJO_1411_18.
   PubMed Web of Science ®Google Scholar